Sangamo Therapeutics, Inc. (SGMO)
NASDAQ·Healthcare·Biotechnology
$0.19
-7.24%
Mkt Cap $87.00M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 30, 2026 | $40.23M | $14.23M | -64.63% | $0.01 | -$0.11 | -1318.16% | — | — |
| Q4 2025 Nov 6, 2025 | $40.25M | $581.00K | -98.56% | -$0.03 | -$0.11 | -266.67% | — | — |
| Q3 2025 Aug 7, 2025 | $34.40M | $18.31M | -46.78% | -$0.07 | -$0.08 | -14.29% | — | — |
| Q2 2025 May 12, 2025 | $7.42M | $6.44M | -13.21% | -$0.11 | -$0.14 | -27.27% | — | — |
| Q1 2025 Mar 17, 2025 | $11.70M | $7.55M | -35.46% | -$0.09 | -$0.11 | -22.22% | — | — |
| Q4 2024 Nov 12, 2024 | $10.32M | $49.41M | +378.95% | $0.01 | $0.04 | +237.84% | — | — |
| Q3 2024 Aug 6, 2024 | $8.26M | $356.00K | -95.69% | -$0.16 | -$0.17 | -6.25% | — | — |
| Q2 2024 May 9, 2024 | $6.36M | $481.00K | -92.43% | -$0.22 | -$0.27 | -22.73% | — | — |
| Q1 2024 Mar 13, 2024 | $8.10M | $2.04M | -74.79% | -$0.25 | -$0.34 | -36.00% | — | — |
| Q4 2023 Nov 1, 2023 | $10.40M | $9.40M | -9.63% | -$0.33 | -$0.34 | -3.03% | — | — |
| Q3 2023 Aug 8, 2023 | $14.83M | $6.83M | -53.91% | -$0.35 | -$0.37 | -5.71% | — | — |
| Q2 2023 May 8, 2023 | $24.06M | $157.96M | +556.51% | -$0.33 | $0.12 | +136.36% | — | — |
| Q1 2023 Feb 22, 2023 | $26.86M | $27.23M | +1.39% | -$0.36 | -$0.32 | +11.11% | — | — |
| Q4 2022 Nov 3, 2022 | $26.59M | $26.46M | -0.48% | -$0.35 | -$0.34 | +2.86% | — | — |
| Q3 2022 Aug 4, 2022 | $24.63M | $29.38M | +19.28% | -$0.35 | -$0.29 | +17.14% | — | — |
| Q2 2022 May 5, 2022 | $27.29M | $28.23M | +3.46% | -$0.32 | -$0.30 | +6.25% | — | — |
| Q1 2022 Feb 24, 2022 | $26.82M | $27.99M | +4.34% | -$0.34 | -$0.26 | +23.53% | — | — |
| Q4 2021 Nov 4, 2021 | $25.19M | $28.56M | +13.39% | -$0.34 | -$0.33 | +2.94% | — | — |
| Q3 2021 Aug 5, 2021 | $26.48M | $27.87M | +5.26% | -$0.30 | -$0.33 | -10.00% | — | — |
| Q2 2021 May 4, 2021 | $24.00M | $26.28M | +9.50% | -$0.29 | -$0.32 | -10.34% | — | — |